# CoreRX Inc. – FDA Inspection, Jun 21, 2019

Source: https://www.keypedia.com/records/fda_inspections/corerx-inc/b803f376-82ec-4a52-865c-0160cdf3770b
Source feed: FDA_Inspections

> FDA inspection 1094038 of CoreRX Inc., June 21, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094038
- Company Name: CoreRX Inc.
- Inspection Date: 2019-06-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1304588 - 2026-02-26](https://www.keypedia.com/records/fda_inspections/corerx-inc/956f34ef-816f-43f4-bdfd-ba4552b1e37e)
- [FDA Inspection 1264769 - 2025-03-20](https://www.keypedia.com/records/fda_inspections/corerx-inc/2ad11a9c-e4df-4503-8667-a3b01206638f)
- FDA Inspection 1151289 - 2021-08-13
- FDA Inspection 1119912 - 2020-03-06
- [FDA Inspection 1105141 - 2019-06-14](https://www.keypedia.com/records/fda_inspections/corerx-inc/eca31204-eefa-4624-9cb1-e52a10251f01)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jose-f-velez/0d1951e8-3aa5-48ff-bc54-1fae8a7a57c9)
- [Issuing Officer](https://www.keypedia.com/people/naveen-b-kanthamneni/b6ac825f-1ec8-4857-b772-86ae2c6ea1cd)

Company: https://www.keypedia.com/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9